Abirateron Sandoz 250 mg
Abirateron Sandoz 250 mg is a medicine authorised by Swissmedic under authorisation number 67818. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 26 October 2021 and the authorisation is valid without a time limit. ATC code L02BX03 places the medicine in the group Endocrine therapy.
| Authorisation number | 67818 |
|---|---|
| Name | Abirateron Sandoz 250 mg |
| Full name | Abirateron Sandoz 250 mg, Filmtabletten |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | L02BX03 |
| First authorisation | 26 October 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Abirateron Sandoz 250 mg, Filmtabletten | B | 26 October 2021 |
| 2 | Abirateron Sandoz 500 mg, Filmtabletten | B | 26 October 2021 |
| 3 | Abirateron Sandoz 1000 mg, Filmtabletten | B | 12 April 2022 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 56 | Tablette(n) | L02BX03 | 07.16.2. | B |
| 3 | 28 | Tablette(n) | L02BX03 | 07.16.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Abirateron Sandoz 250 mg authorised in Switzerland?
Yes. Abirateron Sandoz 250 mg is authorised by Swissmedic under authorisation number 67818, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Abirateron Sandoz 250 mg have?
Abirateron Sandoz 250 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Abirateron Sandoz 250 mg?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.